The hepatic steatosis index (HSI) was originally a simple screening tool constructed by Lee et al. (13) for NAFLD, consisting of the ALT/AST ratio, BMI, diabetes status, and gender, with an AUC and 95% CI of 0.812 (0.801–0.824). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.